This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHepatitis C virus research · Hepatitis B Virus Studies · Liver Disease Diagnosis and Treatment
After publication of the Expression of Concern on this article [1, 2], additional concerns were raised about results presented in Figs 2 and 7. Specifically:
In response to the concerns listed above and in [2], the corresponding author stated that the underlying data for the experiments in question are no longer available.
In light of the extent of the concerns listed above and in [2] that cannot be resolved in the absence of the original underlying data and which question the reliability of the reported results and conclusions, the PLOS ONE Editors retract this article.
RFG agreed with the retraction. RP, SH, SC, PKC, SDatta, RK, CEC, ZH, HZ, and LAB either did not respond directly or could not be reached. SDash did not agree with the retraction and stands by the article’s findings.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Panigrahi R, Hazari S, Chandra S, Chandra PK, Datta S, Kurt R, et al. (2013) Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation. P Lo S ONE 8(8): e 72791. 10.1371/journal.pone.0072791 24009705 PMC 3751885 · doi ↗ · pubmed ↗
- 2The PLOS ONE Editors (2022) Expression of Concern: Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation. P Lo S ONE 17(3): e 0266498. 10.1371/journal.pone.0266498 35358293 PMC 8970492 · doi ↗ · pubmed ↗
